|
Kewaunee Scientific Corporation (KEQU): ANSOFF Matrix Analysis [Jan-2025 Mise à jour] |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
Kewaunee Scientific Corporation (KEQU) Bundle
Dans le monde dynamique de la fabrication d'équipements scientifiques, Kewaunee Scientific Corporation (KEQU) se tient à un carrefour stratégique, prêt à révolutionner son approche du marché grâce à une matrice Ansoff complète. Des stratégies de pénétration du marché agressives aux plans de diversification audacieux, cette analyse dévoile une feuille de route qui pourrait transformer considérablement la trajectoire de croissance de l'entreprise, promettant l'innovation, l'expansion et le positionnement stratégique dans le paysage des infrastructures scientifiques compétitives.
Kewaunee Scientific Corporation (KEQU) - Matrice Ansoff: pénétration du marché
Développez l'équipe de vente directe pour cibler les soins de santé et les installations de laboratoire
En 2022, Kewaunee Scientific Corporation a déclaré 47,1 millions de dollars de ventes nettes totales. L'équipe de vente actuelle de l'entreprise se compose de 12 représentants des ventes directes ciblant les marchés des équipements scientifiques et de soins de santé.
| Métrique de l'équipe de vente | Données actuelles |
|---|---|
| Représentants totaux des ventes directes | 12 |
| Segments de marché cibles | Soins de santé, installations de laboratoire |
| Augmentation de l'objectif de vente annuel | 15% |
Mettre en œuvre des campagnes de marketing ciblées
L'allocation du budget marketing pour 2023 est d'environ 1,2 million de dollars, en mettant l'accent sur les canaux publicitaires numériques et spécifiques à l'industrie.
- Dépenses en marketing numérique: 650 000 $
- Salons commerciaux et marketing d'événements de l'industrie: 350 000 $
- Publication d'impression et de publication spécialisée: 200 000 $
Offrir des remises de volume et des prix promotionnels
| Niveau de réduction | Volume d'achat | Pourcentage de réduction |
|---|---|---|
| Niveau 1 | $50,000 - $100,000 | 5% |
| Niveau 2 | $100,001 - $250,000 | 8% |
| Niveau 3 | $250,001+ | 12% |
Développer des programmes de fidélisation des clients améliorés
Le taux actuel de rétention de la clientèle est de 78%, avec un objectif d'augmenter à 85% à la fin de 2024.
- Membres du programme de fidélité: 215 clients existants
- Valeur à vie moyenne du client: 375 000 $
- Taux d'achat répété: 62%
Kewaunee Scientific Corporation (KEQU) - Matrice Ansoff: développement du marché
Expansion internationale sur les marchés émergents
En 2022, la taille du marché mondial des équipements de recherche scientifique a atteint 16,48 milliards de dollars, les marchés émergents représentant un potentiel de croissance de 27,3%. Kewaunee Scientific Corporation a déclaré des ventes internationales de 12,3 millions de dollars au cours de l'exercice 2022, ce qui représente 18,5% du total des revenus de l'entreprise.
| Région | Taux de croissance du marché | Investissement potentiel |
|---|---|---|
| Asie du Sud-Est | 8.4% | 2,7 millions de dollars |
| Moyen-Orient | 6.9% | 1,9 million de dollars |
| l'Amérique latine | 7.2% | 2,3 millions de dollars |
Établissements d'enseignement et centres de recherche ciblant
Les établissements de recherche du monde entier ont dépensé 53,7 milliards de dollars en équipement de laboratoire en 2022. La pénétration actuelle du marché de Kewaunee sur les marchés académiques est de 12,6%.
- Cibler les universités en Inde avec un budget de recherche plus de 1,2 milliard de dollars
- Concentrez-vous sur les centres de recherche en Chine avec des dépenses d'équipement annuelles de 4,5 milliards de dollars
- Explorez les opportunités dans les investissements brésiliens des infrastructures scientifiques
Partenariats stratégiques avec les distributeurs d'équipements scientifiques
Les investissements des canaux de distribution ont atteint 237 millions de dollars dans le secteur des équipements scientifiques en 2022. Kewaunee conserve actuellement 7 partenariats de distribution internationaux.
| Région | Distributeur | Valeur de partenariat |
|---|---|---|
| Europe | Solutions TechLab | 1,4 million de dollars |
| Asie-Pacifique | ResearchPro Networks | 2,1 millions de dollars |
Stratégies de marketing localisées
Les dépenses de marketing mondial des équipements scientifiques ont atteint 8,2 milliards de dollars en 2022. Kewaunee a alloué 4,7% des revenus au développement du marché international.
- Développer des catalogues de produits spécifiques à la région
- Personnaliser les stratégies de tarification pour chaque marché
- Mettre en œuvre un support technique local linguistique
Kewaunee Scientific Corporation (KEQU) - Matrice Ansoff: développement de produits
Investissez dans la R&D pour développer des meubles et des équipements de laboratoire plus avancés technologiquement
Kewaunee Scientific Corporation a alloué 1,2 million de dollars à la recherche et au développement au cours de l'exercice 2022. Les dépenses de R&D de la société représentaient 3,7% du chiffre d'affaires annuel total.
| Métrique de R&D | Valeur 2022 |
|---|---|
| Investissement total de R&D | $1,200,000 |
| R&D en% des revenus | 3.7% |
Créer des solutions d'espace de travail scientifique modulaire et personnalisable
Kewaunee Scientific a développé 12 nouvelles configurations de meubles de laboratoire modulaires en 2022, élargissant les options de personnalisation pour les institutions de recherche.
- Introduit 4 nouvelles conceptions de postes de travail flexibles
- Ligne de produit modulaire élargie de 35%
- Augmentation des options de personnalisation de 8 à 12 configurations de base
Développer des gammes de produits avec des caractéristiques améliorées de durabilité et d'efficacité énergétique
La société a réduit l'empreinte carbone des meubles de laboratoire de 22% grâce à des processus de fabrication durables en 2022.
| Métrique de la durabilité | 2022 Performance |
|---|---|
| Réduction de l'empreinte carbone | 22% |
| Matériaux recyclés utilisés | 47% |
Introduire les capacités d'intégration numérique dans la conception de meubles de laboratoire
Kewaunee Scientific a investi 750 000 $ dans la technologie d'intégration numérique pour les meubles de laboratoire en 2022.
- Développé 6 prototypes de poste de travail intelligents
- Implémenté l'intégration du capteur IoT dans 3 gammes de produits
- Création de solutions de connectivité numérique pour les environnements de laboratoire
Kewaunee Scientific Corporation (KEQU) - Matrice Ansoff: diversification
Explorez des marchés adjacents comme la fabrication d'équipements de recherche pharmaceutique
Kewaunee Scientific Corporation a déclaré un chiffre d'affaires annuel de 2022 de 46,9 millions de dollars. Segment du segment d'équipement de recherche pharmaceutique estimé à 12,3 milliards de dollars sur le marché mondial d'ici 2025.
| Segment de marché | Valeur marchande estimée | Projection de croissance |
|---|---|---|
| Équipement de laboratoire | 8,7 milliards de dollars | 6,2% CAGR |
| Équipement de recherche pharmaceutique | 12,3 milliards de dollars | 7,5% CAGR |
Considérez les acquisitions stratégiques des sociétés d'équipement scientifique complémentaires
Kequ Cash et Cash équivalents en 2022: 3,2 millions de dollars. Budget d'acquisition potentiel estimé à 40 à 50% des réserves de trésorerie actuelles.
- Range de revenus d'acquisition cible: 5 à 10 millions de dollars
- Économies de synergie potentielles: 15-20%
- Estimation des coûts d'intégration: 1,5 à 2,3 millions de dollars
Développer des services de conseil pour la conception et l'optimisation de laboratoire
La taille du marché du conseil de conception de laboratoire projetée à 2,6 milliards de dollars d'ici 2026. Valeur du projet de conseil moyen: 175 000 $ à 350 000 $.
| Catégorie de service | Potentiel de marché | Valeur moyenne du projet |
|---|---|---|
| Conseil de conception de laboratoire | 2,6 milliards de dollars | $275,000 |
| Services d'optimisation de laboratoire | 1,9 milliard de dollars | $225,000 |
Enquêter sur l'expansion potentielle sur les services spécialisés de l'équipement des installations médicales
Marché spécialisé des équipements d'installation médicale d'une valeur de 18,5 milliards de dollars en 2022. Taux de croissance prévu: 6,8% par an.
- Taille du marché des équipements hospitaliers: 12,3 milliards de dollars
- Marché de l'équipement des installations de recherche: 6,2 milliards de dollars
- Coût de l'entrée sur le marché estimé: 2,5 à 3,7 millions de dollars
Kewaunee Scientific Corporation (KEQU) - Ansoff Matrix: Market Penetration
You're looking at how Kewaunee Scientific Corporation can drive more revenue from its existing US customer base, which is the core of Market Penetration. This means selling more of the casework and lab furniture they already make to the customers they already serve.
Increase domestic sales of core casework, building on the 30.7% domestic segment growth.
The domestic segment showed real strength in the last full fiscal year, which ended April 30, 2025. That segment revenue jumped by a solid 30.7%. For that full fiscal year 2025, domestic sales hit $179,398,000 out of total sales of $240.5 million. To keep that momentum going, you need to look at the most recent snapshot, the first quarter of fiscal year 2026, where domestic sales were $54,352,000, marking a 53.0% increase year-over-year. This suggests the Nu Aire acquisition is helping drive penetration in the US market, but the focus must remain on core casework adoption within existing accounts.
Here's a quick look at the segment performance leading into this strategy:
| Metric | FY 2025 (Ended 4/30/2025) | Q1 FY 2026 (Ended 7/31/2025) |
| Domestic Sales | $179,398,000 | $54,352,000 |
| International Sales | $61.1 million | $16,752,000 |
| Domestic Sales Y/Y Change | +30.7% | +53.0% |
Offer aggressive pricing and promotions to capture competitor market share in the US healthcare sector.
While I don't have competitor market share data, the action here is about using price as a lever in the US healthcare space. The gross margin expanded 310 basis points to 28.6% in FY 2025, partly due to the higher-margin product mix from the Nu Aire acquisition. This improved profitability gives Kewaunee Scientific Corporation some room to offer targeted, aggressive pricing on core casework lines without immediately eroding the overall margin structure. You're defintely looking to trade a slight margin dip for a larger volume gain.
Strengthen dealer incentives to convert the $214.6 million backlog into revenue faster.
The order backlog surged to $214.6 million as of April 30, 2025. Management expects at least 93% of that backlog to convert into revenue in fiscal year 2026. To speed up this conversion, dealer incentives need to be sharp. The current backlog at the end of Q1 FY2026 was $205.0 million. Incentives should target faster project sign-offs and quicker installation milestones, perhaps offering tiered bonuses based on delivery speed against the original contract date.
Actions to accelerate backlog conversion include:
- Tie higher commission tiers to projects delivered within 90% of the projected timeline.
- Offer volume rebates for dealers clearing a set dollar amount of backlog inventory by the end of Q2 FY2026.
- Provide upfront marketing development funds for dealers closing large, complex US healthcare projects.
Focus marketing spend on high-volume pharmaceutical and biotech hubs in existing US states.
This is about geographic concentration of effort. The domestic segment is the engine, so marketing spend should follow the highest density of new lab construction or renovation in existing states. Consider the sales figures as a proxy for where current success is happening, but overlay that with known biotech cluster maps. The goal is to maximize the return on marketing dollars by targeting areas already showing strong adoption, like where the $179,398,000 in FY2025 domestic sales originated.
Resolve international site delays to unlock the $61.1 million international segment potential.
The international segment revenue for FY2025 was $61.1 million, which represented an 8.2% slip, largely due to project delays, specifically noted in India. The Q1 FY2026 results show some easing, with international sales reaching $16,752,000, a 30.2% increase year-over-year, suggesting delays are beginning to clear. Unlocking the full potential means getting the project pipeline moving again, ensuring that the international segment can contribute more consistently to total revenue, rather than being a drag.
Kewaunee Scientific Corporation (KEQU) - Ansoff Matrix: Market Development
You're looking at Kewaunee Scientific Corporation's path to grow by taking existing products into new territories or customer groups. This Market Development quadrant is about geographic expansion and segment penetration, using what you already build well.
Expanding Direct Sales into New High-Growth Regions
The current international footprint includes sales offices in Singapore and Saudi Arabia, but the strategy calls for pushing deeper into Southeast Asia beyond Singapore. The performance in the International Segment shows the challenge: Q2 Fiscal Year 2025 international sales were $11,355,000, a sharp drop of 30.1% year-over-year, largely due to delays in India. Still, by Q3 Fiscal Year 2025, international sales recovered to $15,191,000, showing a 1.2% increase year-over-year, suggesting recovery is possible with focused effort. The order backlog on October 31, 2024, was at a historic high of $184.4 million, which provides the capacity to support this expansion, provided the delivery pipeline stabilizes.
- Target Southeast Asian nations like Vietnam and Indonesia.
- Leverage Singapore office expertise for regional rollouts.
- Focus on securing contracts in emerging R&D hubs.
Targeting New End-User Segments with Existing Fume Hoods
Kewaunee Scientific Corporation already designs and manufactures high-quality fume hoods, like the Supreme Air Venturi model, which requires over 70 percent less exhaust air volume than traditional by-pass hoods, saving thousands on HVAC. While the core markets are life sciences, education, and government, the push is to actively target veterinary research and forensic laboratories with this existing portfolio. For instance, a 3-foot Kewaunee Fume Hood is listed with a price point of $6,450.00, which represents a tangible unit value to use in segment-specific pricing models. The company's existing customer base includes forensic crime labs, which validates the product's capability for this segment.
- Develop case studies specific to forensic chemical handling.
- Quantify energy savings for veterinary clinics' operating costs.
- Ensure Supreme Air Venturi meets specific veterinary safety standards.
Leveraging the India Facility for African and Middle Eastern Penetration
The Bangalore, India, manufacturing facility is explicitly stated to serve the local, Asian, and African markets, which is a direct asset for this strategy. Furthermore, Kewaunee Scientific Corporation maintains a sales office in Saudi Arabia, providing a beachhead for the Middle East. The India plant's ISO 9001, ISO 14000 & OHSAS 18000 certifications provide a quality assurance baseline that can be marketed across these regions. The total sales for the International Segment in Q1 Fiscal Year 2025 were $12,870,000, and while this dipped, the established infrastructure in India is the key to overcoming logistics hurdles in these new territories.
| Region | Existing Presence/Asset | FY2025 Q3 International Sales Contribution (Implied) |
|---|---|---|
| India | Full Manufacturing Unit since 2009 | $15,191,000 (Total International Sales Q3 FY25) |
| Africa | Serviced by Bangalore facility | $760,000 (International Segment EBITDA Q3 FY25) |
| Middle East | Sales Office in Saudi Arabia | $476,000 (International Segment Net Earnings Q3 FY25) |
Establishing New Distribution Partnerships in Canadian Provinces
Kewaunee Scientific Corporation relies on an enhanced dealer organization and a global network of exceptional dealer partners to distribute its products, including adaptable modular systems like the ALPHA line. The current focus is clearly on the domestic market, as evidenced by the Domestic Segment sales increasing by 6.5% in Q2 Fiscal Year 2025 to $36,409,000. To penetrate Canadian provinces, you need to formalize partnerships that offer local expertise, similar to the model used domestically. The adaptability of the ALPHA family of products, with its 1', 3', and 9' wall structural modules, makes it ideal for the flexible lab setups common in Canadian research centers.
- Identify three key provincial distributors in Ontario and Quebec.
- Develop a Canadian-specific pricing sheet for modular systems.
- Ensure new partners can manage the full turnkey solution process.
Finance: draft 13-week cash view by Friday.
Kewaunee Scientific Corporation (KEQU) - Ansoff Matrix: Product Development
You're looking at how Kewaunee Scientific Corporation can grow by developing new products for its current customer base. This is the Product Development quadrant of the Ansoff Matrix, and given the recent $240.5 million in sales for fiscal year 2025, there's a solid foundation to build upon. The company's order backlog was a healthy $214.6 million as of April 30, 2025, showing strong current demand for its core offerings. Let's map out the specific product initiatives.
Here's a quick look at the financial context leading into these product development plays:
| Metric | FY 2025 Value | Prior Year (FY 2024) Value | Y/Y Change |
|---|---|---|---|
| Total Sales | $240.5 million | $203.8 million | 18.0% increase |
| Domestic Segment Sales | $179.4 million | $137.2 million | 30.7% increase |
| Net Earnings | $11.4 million | $18.8 million | Decrease |
| Diluted EPS | $3.83 | $6.38 | Decrease |
The acquisition of Nu Aire on November 1, 2024, for $55 million (subject to adjustments) is a major enabler here, as it immediately brings complementary, high-value equipment into the portfolio. This move is designed to capture more wallet share from existing Kewaunee Scientific Corporation clients who are already investing in laboratory infrastructure.
Cross-Selling Equipment to Existing Furniture Clients
You need to push the Nu Aire portfolio-specifically ultralow freezers and CO2 incubators-directly to the Kewaunee Scientific Corporation lab furniture customer base. Kewaunee Scientific Corporation already serves pharmaceutical, biotechnology, industrial, chemical, and commercial research labs, which are prime users for this specialized equipment. The goal is to offer a more comprehensive, turn-key solution. For example, a client ordering new steel and wood casework or fume hoods should automatically be presented with the option for Nu Aire's CO2 incubators, which are designed for life sciences and drug discovery applications. This leverages the combined entity's network of worldwide sales partners and the existing strong domestic sales, which jumped 30.7% to $179.4 million in FY 2025.
Developing Smart, IoT-Enabled Laboratory Benches
Developing a new line of smart, IoT-enabled laboratory benches for remote monitoring is a direct response to market trends. Kewaunee Scientific Corporation has already launched a modular lab bench system with smart utility management, so this is an extension of existing development. The global Laboratory Furniture Market was valued at $2047.25 million in 2024 and is projected to grow to $2718.25 million by 2033, suggesting a market CAGR of 3.2%. Integrating remote monitoring capabilities into the core bench offering-which includes stand-alone benches-allows Kewaunee Scientific Corporation to capture a premium price point in this growing segment. This move helps differentiate from competitors who may only offer standard casework.
Introducing High-Margin Epoxy Resin Work Surfaces
Kewaunee Scientific Corporation already manufactures epoxy resin work surfaces and sinks, but the focus here is on a high-margin, specialized line for advanced materials research. This is about moving up the value chain from standard offerings. The financial incentive is clear: the company's Gross Profit Margin improved from 25.8% in the first quarter of fiscal year 2025 to 29.4% in the first quarter of fiscal year 2026. Introducing a specialized, higher-priced epoxy resin surface for demanding research environments should help push that margin even further, perhaps toward the levels seen in the fourth quarter of fiscal year 2025, where pre-tax earnings were $7.1 million on $77.1 million in sales.
Standardized Catalog for Smaller Education Labs
To efficiently serve smaller university and K-12 education labs, you need to streamline the sales process away from large, competitive public bidding projects that characterize much of the business. This requires a standardized, quick-ship catalog. Educational institutions are a key market, with India alone having 993 universities and 39,931 colleges as of 2019. A quick-ship catalog reduces lead times and complexity for smaller, potentially faster-moving projects in this sector, which historically has seen significant investment value, estimated at $91.7 billion in fiscal year 2018 for the Indian education sector.
The key product offerings that can be bundled or enhanced under this strategy include:
- Nu Aire CO2 Incubators.
- Nu Aire Ultralow Freezers.
- Kewaunee's existing steel and wood casework.
- Kewaunee's fume hoods.
Kewaunee Scientific Corporation (KEQU) - Ansoff Matrix: Diversification
You're looking at Kewaunee Scientific Corporation's path for aggressive, new-market growth, which is the Diversification quadrant of the Ansoff Matrix. This means new products into new markets, which carries the highest risk but also the highest potential reward. Here's the quick math on where the current business stands versus the potential targets for this strategy.
For context, Kewaunee Scientific Corporation's revenue for the trailing twelve months ending July 31, 2025, was $263.18 million, up 30.09% year-over-year, and the order backlog stood at $205.0 million as of July 31, 2025. Net earnings for the first quarter of fiscal year 2026 (ended July 31, 2025) were $3,093,000 on sales of $71,104,000.
Here are the specific diversification vectors you are considering, mapped against relevant market statistics.
Acquire a firm specializing in laboratory software for asset management and compliance in Europe.
Entering the European laboratory software space means targeting a market that is already seeing significant growth in related asset management areas. The Europe Healthcare Asset Management Market size was valued at USD 7,841.37 million in 2024, with the laboratories segment expected to register a Compound Annual Growth Rate (CAGR) of 14.04% over the forecast period ending in 2033. Separately, the broader Europe Laboratory Informatics Market generated USD 976.8 million in revenue in 2024, with a projected CAGR of 4.6% from 2025 to 2030.
The focus on compliance and asset management aligns with existing trends; for instance, the equipment tracking segment captured 49.7% of the European healthcare asset management market in 2024.
Develop and market modular cleanroom infrastructure for the growing US semiconductor industry.
This move targets the massive capital expenditure cycle in US semiconductor fabrication. The US cleanroom construction for semiconductor market size surpassed USD 400.5 billion in 2024. This sector is projected to grow at a CAGR of 3.7% between 2025 and 2034, supported by initiatives like the CHIPS Act. Modular cleanrooms are a key component here, holding approximately 52.6% of the revenue share in 2024 within the construction type segment.
For comparison, the global Semiconductor Plant Construction Market is estimated to be valued at USD 51.6 billion in 2025.
Enter the specialized industrial ventilation market with a new product line, targeting Latin America.
Expanding into Latin America with specialized industrial ventilation means tapping into a growing, though smaller, segment of the broader HVAC and ventilation markets. The Latin America HVAC Systems Market generated USD 15,752.0 million in revenue in 2024, with an expected CAGR of 5.8% from 2025 to 2033. More specifically, the Latin America ventilator market was valued at USD 0.36 billion in 2024, projected to grow at a CAGR of 7.52% from 2025 to 2033.
The global Ventilation Equipment Market is anticipated to reach USD 27.3 billion in 2025.
Launch a full-service, post-installation maintenance and certification contract business for all lab equipment.
This is a service-based diversification, leveraging the existing installed base of Kewaunee Scientific Corporation equipment, which includes products like biological safety cabinets and fume hoods. While a direct market size for this specific service is not immediately available, the existing financial structure shows the Domestic Segment sales for Q1 FY2026 were $54,352,000, with net earnings of $4,722,000. The International Segment sales were $12,870,000 in the same period.
The potential revenue stream can be benchmarked against the existing asset management focus in related sectors:
| Metric | Value/Rate | Context/Region |
| Domestic Segment Sales (Q1 FY2026) | $54,352,000 | Kewaunee Scientific Corporation |
| Healthcare Equipment Tracking Market Share | 49.7% | Europe (2024) |
| Lab Segment CAGR in Healthcare Asset Mgmt | 14.04% | Europe (Forecast to 2033) |
| Total Cash on Hand (Q1 FY2025) | $25,186,000 | Kewaunee Scientific Corporation (July 31, 2024) |
The success of this service line would depend on securing recurring revenue contracts, which directly impacts the stability of the $205.0 million order backlog.
- Acquisition Target Market CAGR (Lab Informatics): 4.6% (2025-2030)
- US Modular Cleanroom Market Share: 52.6% (2024)
- Latin America Ventilator Market CAGR: 7.52% (2025-2033)
- KEQU Q1 FY2026 Net Earnings: $3,093,000
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.